efficient cancer treatment
novel treatment
individual patients
high cell densities
promising results of autologous cell therapy
Automated autologous cell therapy system
high absolute cell numbers
cancer types
dedicated bioreactors
health concerns
resulting survival rates of patients
global burden of cancer
World Health Organization
major health problems
expansion of TILs
cost of years
specialised hospitals
commercial potential
years of healthy life
efficient therapies available
extended number of hospitals
related deaths
innovative SMEs
middle-aged people
ill-health
tumour
healthcare biotechnology sector - SMEInst
large impact
disability
older adults
early death
topic
application
cardiovascular diseases
need
lymphocytes
use
approach
solid tumors
single course
handful of institutions
cancers
metastatic melanoma
immunotherapy
production
sterile cleanroom
Publication date
project
aim